AU2013203913A1 — Radiopharmaceutical composition
Assigned to GE Healthcare Ltd · Expires 2013-05-02 · 13y expired
What this patent protects
Abstract The present invention relates to radiopharmaceuticals and in particular to a radiopharmaceutical composition comprising a compound of Formula I: R R R' 8 Rz and polysorbate as an excipient. The radiopharmaceutical composition of the invention reduces problems encountered…
USPTO Abstract
Abstract The present invention relates to radiopharmaceuticals and in particular to a radiopharmaceutical composition comprising a compound of Formula I: R R R' 8 Rz and polysorbate as an excipient. The radiopharmaceutical composition of the invention reduces problems encountered with prior art compositions comprising the same class of compounds. Also provided by the invention is a method for the preparation of the radiopharmaceutical composition of the invention as well as particular uses of the radiopharmaceutical composition.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.